KVUE's Quality Score fell 3 points on Fri, Oct 30, to 9. Its daily swings widened out of the quietest 32.5% of the last 100 days (4 chart checks stopped).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 44% in a year while the S&P 500 rose 12%.
| The chart | Above every average |
| Latest filing | 8-K, Nov 2 |
After its last 4 reports it closed -0.3% on average, higher 2 of 4 times.
Averagefor quality, not price, 8 of 14 chart checks firingWhat the Quality Score means
KVUE is #6 of 9 by Quality Score among Perfumes, Cosmetics & Other Toilet Preparations.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 6 |
Expected to report Thu Feb 4, before the open (in 94 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $3.9B, 3% more than a year ago; a profit of $0.22 a share, from $0.21.
“Net cash flows from operating activities were $1.9 billion vs $1.3 billion in the prior year period, with the improvement driven by an increase in net income and by lower use of working capital.”
| Line | September 27, 2026 | September 28, 2025 |
|---|---|---|
| Self Care | $1.7B | $1.6B |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Oct 30)
No outlook figures read from this release.
Sales grew 0.4% a year over 3 years, fiscal 2022 to 2025.
Pays $0.84 a share a year.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Oct 30, 2026 | +2.2% | -1.3% | open |
| Aug 6, 2026 | -0.7% | -2.5% | -3.5% |
| May 7, 2026 | -1.0% | +0.2% | -2.8% |
Sales grew in two of the last four years, to $15B in 2025. It made a profit in each of the five years.
Its dividends come to 84% of its free cash flow.
| Dividend | $0.84 a share a year |
| Paid out | About $1.6B a year |
| Free cash flow | $1.9B |
| Record | Raised each of the last 2 years |
2 insiders sold $747K across 2 filings in the last 6 months. No open-market buys on record. The newest:
13 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: KVUE is 0.1% of VYM, under 0.1% of VOO, and under 0.1% of IVV, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Jul 31, 2026.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
“The consumer health and personal care sectors are large and dynamic, with a significant number of competitors that vary from well-established consumer packaged goods (“CPG”) companies with well-known legacy businesses globally to emerging niche-oriented brands.”
KVUE scores 9 today, which Breakaway calls Average. It is #6 of 9 in Perfumes, Cosmetics & Other Toilet Preparations by Quality Score, with 8 of 14 chart checks firing. Up 44% in a year while the S&P 500 rose 12%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
KVUE scores 9 today, which Breakaway calls Average (6 to 10). That is #6 of 9 in Perfumes, Cosmetics & Other Toilet Preparations by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind KVUE's 9.
2 insiders sold $747K across 2 filings in the last 6 months. No open-market buys on record. The newest is Heather Howlett, CFO & CAO, who sold $67K on Jun 10. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.